Skip to content

How quickly does lidocaine toxicity happen? A timeline and risk factors

4 min read

Approximately 75% of local anesthetic systemic toxicity (LAST) cases manifest within the first five minutes of administration, particularly following an intravascular injection. The speed of onset depends heavily on the route of administration, making the question of how quickly does lidocaine toxicity happen a critical consideration in clinical practice.

Quick Summary

The onset of lidocaine toxicity can range from seconds to over an hour, depending on the cause, such as accidental intravascular injection versus slower systemic absorption. Factors like dosage, injection site, and patient health all influence the timeline and symptom progression, from initial CNS effects to potential cardiac collapse.

Key Points

  • Onset Can Be Rapid or Delayed: Lidocaine toxicity can occur within seconds to minutes following an intravascular injection, or be delayed up to an hour or more due to systemic absorption.

  • Intravascular Injection is Fastest: The most rapid onset is caused by accidental injection directly into a blood vessel, leading to an immediate and high systemic concentration.

  • Initial Signs are CNS-Related: Early symptoms often include a metallic taste, circumoral numbness, dizziness, and tinnitus before potentially progressing to seizures or cardiovascular collapse.

  • Delayed Cases Can Be Atypical: Some delayed toxicity cases can present with subtle or atypical signs, sometimes involving only cardiovascular symptoms without the typical initial CNS signs.

  • Risk Factors Influence Onset and Severity: Factors like high dose, fast injection rate, injection site vascularity, and patient comorbidities can all impact the onset timeline and severity of toxicity.

  • Prevention is Key: Using the lowest effective dose, aspirating before injection, and using ultrasound guidance are crucial for prevention.

  • Lipid Emulsion is a Key Treatment: Intravenous lipid emulsion (ILE) is a cornerstone of treatment for LAST, helping to sequester the drug from the bloodstream.

In This Article

Lidocaine is a widely used local anesthetic, but its systemic toxicity, known as Local Anesthetic Systemic Toxicity (LAST), is a rare yet serious complication that can affect the central nervous system (CNS) and cardiovascular system. The timing of LAST is highly variable, influenced by the administration method, dosage, and patient-specific factors. While rapid onset is more common, a delayed presentation can also occur, emphasizing the need for vigilance after any lidocaine procedure.

Understanding the Rapid Onset of Toxicity

Rapid onset of lidocaine toxicity, typically occurring within seconds to five minutes of an injection, is usually the result of an accidental intravascular injection. This causes an immediate spike in plasma lidocaine concentration, leading to abrupt and pronounced toxic effects.

The initial warning signs

Early signs of a toxic reaction typically involve the CNS and can include:

  • Circumoral and tongue numbness: A tingling or numb sensation around the mouth.
  • Metallic taste: A distinctive metallic flavor in the mouth.
  • Tinnitus: Ringing in the ears.
  • Dizziness and lightheadedness: Feelings of being unsteady.
  • Auditory and visual disturbances: Difficulty focusing or blurred vision.
  • Restlessness and agitation: Feelings of nervousness or anxiety.

The progression of severe toxicity

If the systemic concentration continues to rise, the initial excitatory CNS signs can quickly progress to more severe and life-threatening conditions, including:

  • Seizures: Uncontrolled electrical activity in the brain.
  • CNS depression: Drowsiness, loss of consciousness, and coma.
  • Cardiovascular effects: Hypotension (low blood pressure), bradycardia (slow heart rate), arrhythmias, and eventually cardiac arrest.

The Possibility of Delayed Onset

While less common, lidocaine toxicity can also have a delayed onset, occurring anywhere from 5 to 60 minutes or even several hours after injection. This slower, more gradual rise in systemic lidocaine levels is usually due to delayed systemic absorption from highly vascular injection sites. This can present a diagnostic challenge, as the symptoms may be subtle or atypical. In some cases, delayed LAST has presented exclusively with cardiovascular symptoms, without the preceding CNS signs. The American Society of Regional Anesthesia and Pain Medicine (ASRA) has noted a shift toward more delayed LAST presentations, possibly due to safer injection techniques.

Factors That Influence Onset Speed

Several factors can influence how quickly and severely lidocaine toxicity manifests:

  • Injection site vascularity: The rate of absorption is dependent on the blood flow at the injection site. For example, absorption from an intercostal nerve block is faster than from a subcutaneous injection.
  • Total dose and concentration: Exceeding the maximum recommended dose of lidocaine or using a higher concentration increases the risk of toxicity.
  • Injection rate: Rapidly injecting the local anesthetic can increase the risk of an inadvertent intravascular injection and higher peak plasma concentrations.
  • Patient factors: Extremes of age (very young or elderly), pregnancy, and pre-existing conditions like hepatic or renal dysfunction can increase susceptibility to toxicity.
  • Use of vasoconstrictors: Adding a vasoconstrictor like epinephrine to the solution slows down systemic absorption, which can delay the onset of toxicity and allow for a higher total dose.

Onset Comparison: Intravascular Injection vs. Systemic Absorption

Feature Intravascular Injection Systemic Absorption
Timing Seconds to 5 minutes 5 to 60+ minutes
Mechanism Accidental injection directly into a blood vessel, causing an immediate spike in plasma concentration Gradual uptake from a highly vascular injection site into the bloodstream
Typical Presentation Usually follows a classic progression: early CNS signs, then seizures and potential cardiovascular collapse Can be delayed and sometimes present atypically, such as with only cardiovascular symptoms
Severity Often more abrupt and severe, requiring immediate intervention Generally less intense in the early stages, but can still progress to severe CNS and cardiac issues
Risk Factors Incorrect technique, proximity to large blood vessels High dosage, highly vascular injection site, patient comorbidities

Prevention and Management

Preventing LAST is paramount and relies on using the lowest effective dose, carefully aspirating before injection, and using ultrasound guidance to visualize the needle and vascular structures. For procedures requiring larger volumes, providers may inject incrementally while constantly communicating with the patient.

If lidocaine toxicity is suspected, healthcare providers follow a protocol of immediate action:

  1. Stop the injection: Halt all lidocaine administration immediately.
  2. Call for help: Alert other medical staff and bring a crash cart.
  3. Manage the airway: Provide 100% oxygen and manage ventilation.
  4. Manage seizures: Administer benzodiazepines to control seizures.
  5. Administer lipid emulsion: Intravenous lipid emulsion (ILE) therapy is a critical treatment that helps sequester the lidocaine in the bloodstream, reducing its toxic effects.
  6. Manage arrhythmias: Use advanced cardiac life support protocols, but with caution, as some standard agents may be harmful.

Conclusion

Understanding how quickly does lidocaine toxicity happen is essential for healthcare professionals administering the anesthetic. The onset is highly variable, ranging from rapid reactions within minutes due to intravascular injection to delayed presentations associated with systemic absorption. Factors like dosage, injection site, and patient health significantly influence the timing and severity of symptoms. Vigilance, careful technique, and being prepared to manage a potential toxic reaction are critical for ensuring patient safety during procedures involving lidocaine. Based on information from the National Center for Biotechnology Information, awareness of both typical and atypical presentations is vital for timely diagnosis and intervention.

Frequently Asked Questions

The initial signs of lidocaine toxicity typically affect the central nervous system and include a metallic taste in the mouth, circumoral numbness (around the mouth), dizziness, lightheadedness, and ringing in the ears (tinnitus).

Yes, although it is more commonly seen within minutes, lidocaine toxicity can have a delayed onset, sometimes occurring an hour or more after administration due to slow systemic absorption from highly vascular injection sites.

The fastest way to experience lidocaine toxicity is through an accidental intravascular injection. This causes an immediate, high concentration of the drug in the bloodstream, leading to symptoms within seconds.

The speed of onset is influenced by the injection site's vascularity, the total dose and concentration of lidocaine, and the rate of injection. Rapid injections and highly vascular sites can lead to quicker systemic absorption and faster onset.

Early onset toxicity (seconds to minutes) is often caused by an intravascular injection and typically shows the classic progression of CNS excitation followed by depression. Delayed onset (over 5 minutes) is due to systemic absorption and can present more subtly, or with atypical symptoms such as only cardiovascular signs.

Emergency treatment involves immediately stopping the injection, managing the patient's airway, controlling seizures with benzodiazepines, and administering intravenous lipid emulsion (ILE) to counteract the toxicity.

Yes, certain patient populations are more susceptible, including very young or elderly patients, pregnant women, and those with underlying liver or kidney dysfunction.

Yes, adding epinephrine (a vasoconstrictor) to the lidocaine solution causes local blood vessels to constrict. This slows down the systemic absorption of the lidocaine, which can delay the onset of toxicity and prolong the anesthetic effect.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.